[Arg2] TG
General Information
DRACP ID DRACP02455
Peptide Name [Arg2] TG
Sequence XRLXGGLXGIX
Sequence Length 11
UniProt ID Not available
PubChem CID Not available
Origin Synthetic (Derived from TG)
Type Synthetic peptide
Classification
Active ACP Membrane lysis
Activity Information
Cell Line | Disease | Cancer Classified | Activity | Assay | Testing Time | Literature |
---|---|---|---|---|---|---|
T67 | Astrocytoma | Carcinoma | EC50=8 μM | MTT assay | 24 h | 1 |
HeLa | Human papillomavirus-related endocervical adenocarcinoma | Carcinoma | EC50=4 μM | MTT assay | 24 h | 1 |
Hemolytic Activity Not available
Normal (non-cancerous) Cytotoxicity Human dermal fibroblasts: EC50=8 μM
Target Not available
Affinity Not available
Mechanism Not available
Nature Anticancer
Structure Information
Helicity Not available
Linear/Cyclic Linear
Disulfide/Other Bond Not available
N-terminal Modification Oct (Fatty acid 1-Octanoyl)
C-terminal Modification Free
Other Modification X(1/4/8)=Aib; X(11)=Lol (Amino alcohol leucinol)
Chiral L
Physicochemical Information
Formula C30H48N10O4
Absent amino acids ACDEFHKMNPQSTVWY
Common amino acids X
Mass 123133
Pl 10.55
Basic residues 1
Acidic residues 0
Hydrophobic residues 3
Net charge 1
Boman Index 266
Hydrophobicity 58.18
Aliphatic Index 106.36
Half Life
/
Extinction Coefficient cystines 0
Absorbance 280nm 0
Polar residues 3
Amino acid distribution
Literature Information
Literature 1
Pubmed ID 27039838
Title The rational search for selective anticancer derivatives of the peptide Trichogin GA IV: a multi-technique biophysical approach
Year 2016
Patent
Patent ID Not available
Patent Title Not available
Other Iinformation Not available
Other Published ID Not available
External Code
DBAASP ID DBAASPS_9389